SNORD63 and SNORD96A as the non-invasive diagnostic biomarkers for clear cell renal cell carcinoma

Table 3 Relationship between clinical characteristics and SNORD63, SNORD96A expression in FFPE, US and plasma

Variables	FFPE		US		Plasma
Variables	SNORD63	SNORD96A	SNORD63	SNORD96A	SNORD63	SNORD96A
Age
< 61	0.8527	0.5048	0.0105*	0.0654	0.1710	0.6177
≥ 61	0.8527	0.5048	0.0105*	0.0654	0.1710	0.6177
Sex
F	0.7128	0.4462	0.9889	0.8299	0.7475	0.8117
M	0.7128	0.4462	0.9889	0.8299	0.7475	0.8117
T stage
T1	0.7994	0.8722	0.8722	0.060	0.7098	0.2791
T2
T3
T4
N stage
N0	0.6919	0.6257	0.7181	0.6384	0.2110	0.3544
N1	0.6919	0.6257	0.7181	0.6384	0.2110	0.3544
M stage
M0	0.6164	0.4695	0.8306	0.8709	0.9748	0.0930
M1	0.6164	0.4695	0.8306	0.8709	0.9748	0.0930
Grade
G1	0.3182	0.1568	0.1722	0.9956	0.4288	0.7813
G2
G3
G4

ISSN: 1475-2867